glp 1 mimetics GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists GLP-1 Receptor Agonists: Mascots &

December 14, 2023

Influencers from Kim Kardashian and Oprah to Elon Musk and Tracy Morgan have all fueled the frenzy, either admitting they take GLP-1 drugs for weight loss or sparking such rumors on social media

A predictor matrix was constructed establishing region-specific relationships, giving full weight to predictors within the same brain region (dHPC, vHPC, Amyg, PFC), partial weight (0.5) to predictors from other regions, and including demographic variables (Group, Treatment, Diet) as full predictors

The Food and Drug Administration (FDA) has approved Eli Lillys Foundayo (orforglipron), a once-daily oral glucagon-like peptide-1 (GLP-1) receptor agonist, which offers a noninjectable option for weight management

10.1016/S2213-8587(23)00388-1 57 NewsomeP